Similarly, Edelman et al. (2019) [41] found a significant correlation between BrAce levels and blood ketone concentrations in type 2 diabetes patients treated with SGLT2 inhibitors, underscoring its potential for ketosis monitoring. Here, SLC5A2 is linked to type 2 diabetes mellitus.